HOME >> BIOLOGY >> NEWS
Altadena chemist wins national award for studying life molecules

Chemist John D. Roberts of Altadena, Calif., will be honored April 3 by the world's largest scientific society for his pioneering studies in technology to better understand molecules important to life. He will receive the 2001 Nakanishi Prize from the American Chemical Society at its 221st national meeting in San Diego.

"Over the last quite a few years, my research group and I have found out much about the structures of molecules and how they work - particularly in biochemical processes," said Roberts, who is professor emeritus of chemistry at the California Institute of Technology, Pasadena.

One of his projects has been studying the action of a class of protein enzymes called proteases, the body's scissors. Despite their role in diseases such as AIDS, proteases also snip up food proteins during digestion and perform other processes critical to life.

The research tool Roberts uses is called nuclear magnetic resonance, for whose development colleagues call him a pioneer in the field. NMR is based on the principle that nuclei - those of carbon, nitrogen and so on - will vibrate at some unique frequency when placed in an energy field. Researchers use NMR to identify and analyze compounds.

Specifically, Roberts used NMR in the 1970s to learn more about why proteases are able to cut up other proteins without cutting up themselves. While many proteins fit into the protease active site, where cleavage takes place, the simple answer is that proteases do not.

But his team uncovered important details: "We showed the way in which three protease amino acids [protein subunits] in particular cooperate with each other to attack the bonds," he said, and at the same time disproved a then-popular theory of action.

Roberts continues active research despite retiring officially in 1988. He and his students are now using NMR to study "how and why certain arrangements of molecules are more favorable than others," he said.

The organic chemist received his u
'"/>

Contact: Rodney Pearson
r_pearson@acs.org
202-872-4400
American Chemical Society
3-Apr-2001


Page: 1 2

Related biology news :

1. UT Southwestern biochemist honored with NIH Directors Pioneer Award
2. NJIT chemist speaks Aug. 25 about compound derived from pine tree
3. NIH roadmap for biomedical research focus of chemists at American Chemical Society meeting
4. U of T research answers key question in biochemistry
5. Carnegie Mellon University hosts ACS-PRF summer school on green chemistry
6. Rutgers chemist uses NMR to elucidate protein-DNA interaction
7. New multidisciplinary research tops chemists meeting Aug. 22-26
8. Wisconsin chemists find a new chink in TBs armor
9. UCLA chemists develop new coating for nanoscale probes
10. High profile publications in biology and biochemistry on rise at UH
11. Biochemist becomes 15th UT Southwestern faculty member serving on National Academy of Sciences

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Altadena chemist wins national award for studying life molecules

(Date:5/21/2013)... University researchers have developed a new method for ... holes in the cell surface. The technique could ... related biological fields. , Bulk electroporation a ... reversible nanopores in the cell membrane that are ... is an increasingly popular method of cell transfection. ...
(Date:5/21/2013)... new University of Michigan Water Center today awarded ... Great Lakes restoration and protection efforts. , The ... diverse projects, including efforts to track the remediation ... techniques to control non-native weedy plant invasions; study ... fish responses to restoration activities. , The grants ...
(Date:5/21/2013)... Researchers at the University of Illinois at Chicago College of ... and stores fat -- its main energy source -- and ... disease, under a new $2 million, 4-year grant from the ... heart changes how it uses fuel for energy. These changes ... disease and are different in men and women, says E. ...
Breaking Biology News(10 mins):Single-cell transfection tool enables added control for biological studies 2U-M Water Center awards $570K in Great Lakes restoration grants 2U-M Water Center awards $570K in Great Lakes restoration grants 3U-M Water Center awards $570K in Great Lakes restoration grants 4Do men's and women's hearts burn fuel differently? 2
(Date:5/22/2013)... , May 22, 2013  Cleveland BioLabs, Inc. (NASDAQ: CBLI) ... the Second Annual Marcum LLP Microcap Conference, May 30, in ... Neil Lyons , CPA, Chief Financial Officer ... programs on May 30 at 1:30 p.m. Eastern Time.  A ... available on the Investors page of the Cleveland BioLabs website ...
(Date:5/22/2013)... Express Diagnostics Int’l, Inc. (EDI) ... are pleased to announce a sponsorship agreement with Erebus ... Zealand distributor of DrugCheck® onsite testing devices, manufactured by ... the Austin 400 May 17-19 in Austin, Texas. , ... involves each car of the Erebus Motorsport team displaying ...
(Date:5/22/2013)... Miami, FL (PRWEB) May 22, 2013 A ... effects of probiotics on athletes to find that those who ... percent longer. The results from the study showed that in ... Probiotic Action, known for their adult acne treatment ... acne, and how it may help their skin condition. ...
(Date:5/21/2013)... , May 22, 2013 First ... formulation of glycopyrronium bromide designed using Prosonix, particle engineering ... developing a portfolio of inhaled Respiratory Medicines by ... with PSX1002 that will assess its effect on lung ... in patients with moderate to severe chronic obstructive pulmonary ...
Breaking Biology Technology:Cleveland BioLabs to Present at Second Annual Marcum LLP Microcap Conference 2Australian Distributor of Express Diagnostics Signs Sponsorship Agreement with V8 Supercar Team 2Adult Acne Treatment, Probiotic Action Shares Insight on New Findings Between Probiotics and Heat Tolerance, and What It Means for Acne Sufferers 2Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 2Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 3Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 4
Cached News: